Wayfinder Biosciences is Media and Information Services (B2B) in United States that focus on relevant molecules business. Founded in 2020. They cover business area such as developer, RNA technology, sustainable biomanufacturing, high-value chemical, medically relevant molecule, invisible molecule, screening, performance, high speed, customer, sample, high throughput, fast fluorescence measurement.
Media and Information Services (B2B)
2020
( 4 years old in 2024 )
Relevant Molecules
-
479 Jessie Street
San Francisco, CA 94103
United States
Private
developerRNA technologysustainable biomanufacturinghigh-value chemicalmedically relevant moleculeinvisible moleculescreeningperformancehigh speedcustomersamplehigh throughputfast fluorescence measurement
* We use standard office opening hours in near Wayfinder Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Wayfinder Biosciences is Media and Information Services (B2B) business from United States that founded in 2020 (4 years old in 2024), Wayfinder Biosciences business is focusing on Relevant Molecules.
Wayfinder Biosciences headquarter office and corporate office address is located in 479 Jessie Street San Francisco, CA 94103 United States.
Wayfinder Biosciences was founded in United States.
In 2024, Wayfinder Biosciences is currently focus on relevant molecules sector.
Above is snippet of Google Trends for "relevant molecules" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Wayfinder Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
